• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sorrento Therapeutics Inc

+ Add to Watchlist

8STN:GR

3.881 EUR 0.003 0.08%

As of 02:02:17 ET on 07/31/2014.

Snapshot for Sorrento Therapeutics Inc (8STN)

Open: 3.881 Day's Range: 3.881 - 3.881 Volume: 0
Previous Close: 3.878 52wk Range: 3.544 - 11.775 1-Yr Rtn: -

Stock Chart for 8STN

No chart data available.
  • 8STN:GR 3.881
  • 1D
  • 1M
  • 1Y
3.878
Interactive 8STN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 8STN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.5300
Est. PEG Ratio -
Market Cap (M EUR) 107.96
Shares Outstanding (M) 27.82
30 Day Average Volume 43
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 8STN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 8STN

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease.

Henry JiPresident/CEOZhenwei MiaoChief Technology Officer
George UyChief Commercial OfficerRichard G VincentExec VP/CFO
More Company Profile & Key Executives for 8STN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil